Top Stories This Week

General Medicine Breaking News
The American Academy of Neurology (AAN) issued ethical guidance for neurologists and neuroscience professionals who care for people with Alzheimer’s disease and other dementias. The new position statement, published in Neurology, was developed by the Ethics, Law, and Humanities Committee, a joint...
Maintaining healthy blood sugar levels in the years immediately following type 2 diabetes diagnosis is critical to lowering risk for future myocardial infarctions [MI] and death, according to a study published in Diabetes Care. For the analysis, Marcus Lind, MD, University of Gothenburg,...
Excessive blood pressure (BP) reduction for acute intracerebral haemorrhage can have dire consequences when kidney function is low, according to a study published in Neurology. Previous clinical studies have shown that intense BP reduction in patients with acute intracerebral haemorrhage can...
Longer exposure to endogenous oestrogen may be associated with increased levels of Alzheimer’s disease biomarkers, according to a study published in Menopause. Prior studies have shown a link between both higher and lower estradiol blood levels and risk of dementia, whereas others have identified...
A transplant of healthy gut microbes followed by fibre supplements benefits patients with severe obesity and metabolic syndrome, according to a study published in Nature Medicine. “These patients were on the best known medications (for metabolic syndrome) and we could improve them further, which...
By Danny Kucharsky VIRTUAL -- June 30, 2021 -- Tirzepatide demonstrated clinically meaningful improvement in glycaemic control and substantial weight loss versus semaglutide in patients with type 2 diabetes patients treated with metformin, according to a study presented at the Virtual 81st...
By Danny Kucharsky VIRTUAL -- June 30, 2021 -- Tirzepatide improved glycaemic control and reduced body weight without increased risk of hypoglycaemia in patients with type 2 diabetes treated with basal insulin glargine, according to a study presented at the Virtual 81st Scientific Sessions of the...
By Danny Kucharsky VIRTUAL -- June 29, 2021 -- Ertugliflozin significantly reduced the likelihood of insulin initiation and delays new insulin initiations by up to 1.8 years versus placebo in insulin-naive patients with type 2 diabetes, according to a study presented at the Virtual 81st Scientific...
By Danny Kucharsky VIRTUAL -- June 29, 2021 -- A short-term intensive treatment targeting normoglycaemia and weight loss with insulin glargine, lixisenatide, metformin, and lifestyle changes can induce sustained remission of type 2 diabetes, according to findings from the REMIT-iGlarLixi study...
By Danny Kucharsky VIRTUAL -- June 29, 2021 -- Dapagliflozin 10 mg reduced the incidence of new-onset type 2 diabetes in patients with chronic kidney disease (CKD), according to a study presented at the Virtual 81st Scientific Sessions of the American Diabetes Association (ADA). Dapagliflozin led...

Pages